GB1448371A - Process for the selective elimination of amino protective groups - Google Patents

Process for the selective elimination of amino protective groups

Info

Publication number
GB1448371A
GB1448371A GB4434373A GB4434373A GB1448371A GB 1448371 A GB1448371 A GB 1448371A GB 4434373 A GB4434373 A GB 4434373A GB 4434373 A GB4434373 A GB 4434373A GB 1448371 A GB1448371 A GB 1448371A
Authority
GB
United Kingdom
Prior art keywords
obut
tyr
thr
asn
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4434373A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of GB1448371A publication Critical patent/GB1448371A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C07K1/063—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for alpha-amino functions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/12—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
    • C07K1/122—Hydrolysis with acids different from HF
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB4434373A 1972-09-22 1973-09-21 Process for the selective elimination of amino protective groups Expired GB1448371A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1386572A CH577464A5 (cg-RX-API-DMAC7.html) 1972-09-22 1972-09-22

Publications (1)

Publication Number Publication Date
GB1448371A true GB1448371A (en) 1976-09-08

Family

ID=4396002

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4434373A Expired GB1448371A (en) 1972-09-22 1973-09-21 Process for the selective elimination of amino protective groups

Country Status (10)

Country Link
US (1) US3862113A (cg-RX-API-DMAC7.html)
JP (1) JPS5724776B2 (cg-RX-API-DMAC7.html)
BE (1) BE805147A (cg-RX-API-DMAC7.html)
CA (1) CA1007224A (cg-RX-API-DMAC7.html)
CH (1) CH577464A5 (cg-RX-API-DMAC7.html)
DE (1) DE2346147A1 (cg-RX-API-DMAC7.html)
FR (1) FR2200250B1 (cg-RX-API-DMAC7.html)
GB (1) GB1448371A (cg-RX-API-DMAC7.html)
HU (1) HU169501B (cg-RX-API-DMAC7.html)
NL (1) NL7313077A (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4328214A (en) * 1979-07-04 1982-05-04 Ciba-Geigy Corporation Cyclopeptides and pharmaceutical preparations thereof and also processes for their manufacture
US4369179A (en) * 1979-12-14 1983-01-18 Ciba-Geigy Corporation Acylpeptides
DD155985A5 (de) * 1979-12-21 1982-07-21 Ciba Geigy Ag Verfahren zur herstellung cyclischr octapeptide
US4701304A (en) * 1985-04-19 1987-10-20 Applied Protein Technologies, Inc. Apparatus for automated synthesis of peptides
US4806654A (en) * 1987-03-23 1989-02-21 Warner-Lambert Company Processes for the preparation of benzo(chalcogeno)(4,3,2-cd)indazoles and intermediates thereof
CN1939529A (zh) * 2002-01-29 2007-04-04 Wyeth公司 用于调节连接蛋白半通道的组合物和方法
MX2010004955A (es) * 2007-11-15 2010-06-30 Avi Biopharma Inc Metodo de sintesis de oligomeros de morfolina.

Also Published As

Publication number Publication date
NL7313077A (cg-RX-API-DMAC7.html) 1974-03-26
CA1007224A (en) 1977-03-22
US3862113A (en) 1975-01-21
FR2200250B1 (cg-RX-API-DMAC7.html) 1976-05-14
DE2346147A1 (de) 1974-03-28
BE805147A (fr) 1974-03-21
HU169501B (cg-RX-API-DMAC7.html) 1976-12-28
JPS5724776B2 (cg-RX-API-DMAC7.html) 1982-05-26
FR2200250A1 (cg-RX-API-DMAC7.html) 1974-04-19
CH577464A5 (cg-RX-API-DMAC7.html) 1976-07-15
JPS4985003A (cg-RX-API-DMAC7.html) 1974-08-15

Similar Documents

Publication Publication Date Title
CA1148146A (en) Cyclopeptides and pharmaceutical preparations thereof and also processes for their manufacture
Szabo et al. The bovine insulin-like growth factor (IGF) binding protein purified from conditioned medium requires the N-terminal tripeptide in IGF-1 for binding
US4238481A (en) Novel cyclopeptides
AU589674B2 (en) GRF analogs
EP0251615B1 (en) Method of chain combination
CA1140117A (en) Peptides and processes for the manufacture thereof
CA1161033A (en) Acylpeptides
FI92210B (fi) Menetelmä farmaseuttisesti käyttökelpoisten GRF-analogien valmistamiseksi
CA2032153A1 (fr) Application de nouveaux fragments d'adn en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
US4861755A (en) Peptides with vasorelaxant, natriuretic and diuretic effects a process for their preparation, agents containing them, and their use
US4224199A (en) Somatostatin analogs having a substituted tryptophyl residue in position eight
PT731811E (pt) Chaperonina 10
EP0082568A3 (en) Retro-inverso analogues of c-terminal penta and hexapeptides of substance p.
GB1459303A (en) Peptides and process for their manufacture
Rapoport et al. Synthesis of Carp Proinsulin in Xenopus Ocytes
GB1464774A (en) 13-l-norleucine-14-desamido-motilin a method for preparing it and a therapeutic containing it
KR910000791A (ko) 뉴로키닌 a 길항제
GB1574492A (en) D-ala2,d-lys4-somatostatin
US3862113A (en) Process for the selective elimination of aralkyloxycarbonyl and trityl n-protecting groups with 2,2,2-trifluoroethanol
GB1316545A (en) 1-alpha-aminoisobutyric acid-corticotropin peptides
GB1294771A (en) Thyrocalcitonin derivative
DE69015314D1 (de) Verwendung von adenylzyclase als vakzin gegen bordetella.
US4118380A (en) Decapeptide analogs of somatostatin
CA1091650A (en) Somatostatin analogs and intermediates thereto
GB1259870A (en) Polypeptides

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee